Cardiovascular, anthropometric, metabolic and hormonal profiling of normotensive women with polycystic ovary syndrome with and without biochemical hyperandrogenism
Open Access
- 22 February 2021
- journal article
- research article
- Published by Springer Science and Business Media LLC in Endocrine
- Vol. 72 (3), 882-892
- https://doi.org/10.1007/s12020-021-02648-7
Abstract
Purpose Women with polycystic ovary syndrome (PCOS) present with or without biochemical hyperandrogenism (HAPCOS or non-HAPCOS, respectively). Cardiometabolic and hormonal abnormalities have been reported in women with PCOS, particularly those with hypertension. However, no direct comparison between normotensive (blood pressure n = 69) or non-HAPCOS (n = 180) groups. Results Although within normal ranges, patients with HAPCOS had significantly (p < 0.05) higher peripheral and central systolic blood pressure and pulse pressure, C-reactive protein, low-density lipoprotein cholesterol, triglycerides, glucose, and insulin than subjects with non-HAPCOS, and healthy women. They also had lower N-terminal prohormone of B-type natriuretic peptide (NT-proBNP) concentration. In contrast, their body mass index (BMI) was higher of over 4 kg/m2 than patients with non-HAPCOS and nearly 6 kg/m2 than in healthy participants. Except for BMI, statistical differences in the cardiometabolic profile were of little clinical relevance. Conclusions Young normotensive women with HAPCOS have a worse cardiometabolic profile but lower NT-proBNP concentration than patients with non-HAPCOS. Features of this profile in both PCOS groups are within ranges typical for healthy women. Increased BMI is the only clinically relevant feature differentiating hyperandrogenic from non-hyperandrogenic patients with PCOS, and healthy women.Keywords
This publication has 69 references indexed in Scilit:
- Effects of transdermal testosterone on natriuretic peptide levels in women: a randomized placebo-controlled pilot studyFertility and Sterility, 2012
- Cardiac Natriuretic Peptides, Obesity, and Insulin Resistance: Evidence from Two Community-Based StudiesJournal of Clinical Endocrinology & Metabolism, 2011
- Influence of Sex and Hormone Status on Circulating Natriuretic PeptidesJournal of the American College of Cardiology, 2011
- The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteriaHuman Reproduction, 2009
- Pediatric Brain Natriuretic Peptide Concentrations Vary with Age and Sex and Appear to Be Modulated by TestosteroneClinical Chemistry, 2009
- Lack of association between clinical and biochemical hyperandrogenism in patients with polycystic ovary syndromeFertility and Sterility, 2008
- Effects of androgens on insulin action in women: is androgen excess a component of female metabolic syndrome?Diabetes/Metabolism Research and Reviews, 2008
- Relation of N-terminal pro-brain natriuretic peptide levels and their prognostic power in chronic stable heart failure to obesity statusEuropean Heart Journal, 2008
- Cardiovascular disease in the polycystic ovary syndrome: New insights and perspectivesAtherosclerosis, 2005
- Effect of body mass index on natriuretic peptide levels in patients with acute congestive heart failure: A ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) substudyAmerican Heart Journal, 2005